Both MC1 and MC3 receptors provide protection from cerebral ischemia-reperfusion-induced neutrophil recruitment

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 9, 2015, Pages 1936-1944

  Holloway, Paul M ^a,b   Durrenberger, Pascal F ^a   Trutschl, Marjan ^b   Cvek, Urska ^b   Cooper, Dianne ^c   Orr, A Wayne ^b   Perretti, Mauro ^c   Getting, Stephen J ^d   Gavins, Felicity N E ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

inflammation; leukocyte; melanocortins; neutrophil; stroke

Indexed keywords

ALPHA INTERMEDIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; PADGEM PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; INTERMEDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; CELL ADHESION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE ROLLING; MOUSE; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; COMPLICATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; MALE; MELANOCYTE-STIMULATING HORMONES; MICE; NEUTROPHIL INFILTRATION; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTOR, MELANOCORTIN, TYPE 3; REPERFUSION INJURY; RNA, MESSENGER;

EID: 84940434485     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305348     Document Type: Article

References (28)

1. Sughrue ME, Mehra A, Connolly ES Jr, D'Ambrosio AL, Anti-Adhesion molecule strategies as potential neuroprotective agents in cerebral ischemia: a critical review of the literature. Inflamm Res 2004 53 497 508. doi: 10.1007/s00011-004-1282-0
2. Catania A, Gatti S, Colombo G, Lipton JM, Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 2004 56 1 29. doi: 10.1124/pr.56.1.1
3. Leoni G, Patel HB, Sampaio AL, Gavins FN, Murray JF, Grieco P, Getting SJ, Perretti M, Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion. FASEB J 2008 22 4228 4238. doi: 10.1096/fj.08-113886
4. Leoni G, Voisin MB, Carlson K, Getting S, Nourshargh S, Perretti M, The melanocortin MC(1) receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature. Br J Pharmacol 2010 160 171 180. doi: 10.1111/j.1476-5381.2010.00688.x
5. Chiao H, Foster S, Thomas R, Lipton J, Star RA, Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 1996 97 2038 2044
6. Holloway PM, Smith HK, Renshaw D, Flower RJ, Getting SJ, Gavins FN, Targeting the melanocortin receptor system for anti-stroke therapy. Trends Pharmacol Sci 2011 32 90 98. doi: 10.1016/j.tips.2010.11.010
7. Fielding CA, McLoughlin RM, McLeod L, Colmont CS, Najdovska M, Grail D, Ernst M, Jones SA, Topley N, Jenkins BJ, IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol 2008 181 2189 2195
8. Bottero V, Imbert V, Frelin C, Formento JL, Peyron JF, Monitoring NF-kappa B transactivation potential via real-Time PCR quantification of I kappa B-Alpha gene expression. Mol Diagn 2003 7 187 194
9. Joseph CG, Yao H, Scott JW, Sorensen NB, Marnane RN, Mountjoy KG, Haskell-Luevano C, γ2-Melanocyte stimulation hormone (γ2-MSH) truncation studies results in the cautionary note that γ2-MSH is not selective for the mouse MC3R over the mouse MC5R. Peptides 2010 31 2304 2313. doi: 10.1016/j.peptides.2010.08.025
10. Kathpalia PP, Charlton C, Rajagopal M, Pao AC, The natriuretic mechanism of gamma-melanocyte-stimulating hormone. Peptides 2011 32 1068 1072. doi: 10.1016/j.peptides.2011.02.006
11. Hruby VJ, Lu D, Sharma SD, Castrucci AL, Kesterson RA, al-Obeidi FA, Hadley ME, Cone RD, Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 1995 38 3454 3461
12. Gavins FN, Dalli J, Flower RJ, Granger DN, Perretti M, Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation. FASEB J 2007 21 1751 1758. doi: 10.1096/fj.06-7842com
13. Ishikawa M, Cooper D, Russell J, Salter JW, Zhang JH, Nanda A, Granger DN, Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke 2003 34 1777 1782. doi: 10.1161/01.STR.0000074921.17767.F2
14. Frijns CJ, Kappelle LJ, van Gijn J, Nieuwenhuis HK, Sixma JJ, Fijnheer R, Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 1997 28 2214 2218
15. Wayne Smith C, Potential significance of circulating E-selectin. Circulation 1997 95 1986 1988
16. Harrington EO, Stefanec T, Newton J, Rounds S, Release of soluble E-selectin from activated endothelial cells upon apoptosis. Lung 2006 184 259 266. doi: 10.1007/s00408-005-2589-5
17. Denes A, Pinteaux E, Rothwell NJ, Allan SM, Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target. Cerebrovasc Dis 2011 32 517 527. doi: 10.1159/000332205
18. Zierath D, Tanzi P, Cain K, Shibata D, Becker K, Plasma -melanocyte stimulating hormone predicts outcome in ischemic stroke. Stroke 2011 42 3415 3420. doi: 10.1161/STROKEAHA.111.627331
19. Kang L, McIntyre KW, Gillooly KM, A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice. J Leukoc Biol 2006 80 897 904. doi: 10.1189/jlb.1204748
20. Montero-Melendez T, Patel HB, Seed M, Nielsen S, Jonassen TE, Perretti M, The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties. Am J Pathol 2011 179 259 269. doi: 10.1016/j.ajpath.2011.03.042
21. Sarkar A, Sreenivasan Y, Manna SK, alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages. FEBS Lett 2003 553 286 294
22. Manna SK, Sarkar A, Sreenivasan Y, Alpha-melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase. Eur J Immunol 2006 36 754 769. doi: 10.1002/eji.200535209
23. Zaremba J, Losy J, Early TNF-Alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 2001 104 288 295
24. Liesz A, Bauer A, Hoheisel JD, Veltkamp R, Intracerebral interleukin-10 injection modulates post-ischemic neuroinflammation: an experimental microarray study. Neurosci Lett 2014 579 18 23. doi: 10.1016/j.neulet.2014.07.003
25. Spera PA, Ellison JA, Feuerstein GZ, Barone FC, IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998 251 189 192
26. Lindberg C, Hjorth E, Post C, Winblad B, Schultzberg M, Cytokine production by a human microglial cell line: effects of beta-Amyloid and alpha-melanocyte-stimulating hormone. Neurotox Res 2005 8 267 276
27. Clark WM, Rinker LG, Lessov NS, Al Masaoudi M, Sellge G, Nevzorova YA, Gassler N, Liedtke C, Cubero FJ, Trautwein C, Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000 31 1715 1720
28. Lam LT, Wright G, Davis RE, Lenz G, Farinha P, Dang L, Chan JW, Rosenwald A, Gascoyne RD, Staudt LM, Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood 2008 111 3701 3713. doi: 10.1182/blood-2007-09-111948